Show simple item record

dc.contributor.authorMcGhee, David J M
dc.contributor.authorRoyle, Pamela L
dc.contributor.authorThompson, Paul A
dc.contributor.authorWright, David E
dc.contributor.authorZajicek, John P
dc.contributor.authorCounsell, Carl E
dc.date.accessioned2014-10-28T12:51:01Z
dc.date.available2014-10-28T12:51:01Z
dc.date.issued2013-04-12
dc.identifier23850693
dc.identifier8c54abc2-3add-4873-a24d-ab7de1b14b37
dc.identifier23587062
dc.identifier84877070118
dc.identifier.citationMcGhee , D J M , Royle , P L , Thompson , P A , Wright , D E , Zajicek , J P & Counsell , C E 2013 , ' A systematic review of biomarkers for disease progression in Parkinson's disease ' , BMC Neurology , vol. 13 , 35 . https://doi.org/10.1186/1471-2377-13-35en
dc.identifier.urihttp://hdl.handle.net/2164/3771
dc.format.extent13
dc.format.extent354894
dc.language.isoeng
dc.relation.ispartofBMC Neurologyen
dc.subjectParkinson diseaseen
dc.subjectbiomarkersen
dc.subjectdisease progressionen
dc.subjectclinical trialsen
dc.subjectneuroprotective agentsen
dc.subjectRC0321 Neuroscience. Biological psychiatry. Neuropsychiatryen
dc.subject.lccRC0321en
dc.titleA systematic review of biomarkers for disease progression in Parkinson's diseaseen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Chronic Disease Research Groupen
dc.contributor.institutionUniversity of Aberdeen.Grampian Data Safe Haven (DaSH)en
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.description.statusPeer revieweden
dc.identifier.doi10.1186/1471-2377-13-35


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record